Henry Schein Shares Outstanding 2006-2019 | HSIC

Henry Schein shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Henry Schein shares outstanding for the quarter ending September 30, 2019 were 0.149B, a 3.28% decline year-over-year.
  • Henry Schein 2018 shares outstanding were 0.154B, a 2.84% decline from 2017.
  • Henry Schein 2017 shares outstanding were 0.158B, a 3.37% decline from 2016.
  • Henry Schein 2016 shares outstanding were 0.164B, a 2.69% decline from 2015.
Henry Schein Annual Shares Outstanding
(Millions of Shares)
2018 154
2017 158
2016 164
2015 168
2014 171
2013 175
2012 180
2011 185
2010 187
2009 181
2008 182
2007 182
2006 180
2005 177
Henry Schein Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 149
Q2 2019 149
Q1 2019 151
Q4 2018 154
Q3 2018 154
Q2 2018 154
Q1 2018 154
Q4 2017 158
Q3 2017 158
Q2 2017 159
Q1 2017 160
Q4 2016 164
Q3 2016 164
Q2 2016 165
Q1 2016 165
Q4 2015 168
Q3 2015 168
Q2 2015 168
Q1 2015 169
Q4 2014 171
Q3 2014 171
Q2 2014 172
Q1 2014 173
Q4 2013 175
Q3 2013 175
Q2 2013 176
Q1 2013 178
Q4 2012 180
Q3 2012 179
Q2 2012 181
Q1 2012 181
Q4 2011 185
Q3 2011 186
Q2 2011 187
Q1 2011 186
Q4 2010 187
Q3 2010 187
Q2 2010 187
Q1 2010 185
Q4 2009 181
Q3 2009 183
Q2 2009 181
Q1 2009 179
Q4 2008 182
Q3 2008 183
Q2 2008 184
Q1 2008 185
Q4 2007 182
Q3 2007 183
Q2 2007 181
Q1 2007 180
Q4 2006 180
Q3 2006 180
Q2 2006 180
Q1 2006 178
Q4 2005 177
Q3 2005 177
Q2 2005 176
Q1 2005 176
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $10.584B $13.202B
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics and other alternate care sites. The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of branded products and Henry Schein private-brand products in stock.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.565B 22.38
McKesson (MCK) United States $29.730B 11.66
Align Technology (ALGN) United States $21.670B 55.43
AmerisourceBergen (ABC) United States $19.428B 13.03
Laboratory Of America Holdings (LH) United States $18.962B 17.27
Cardinal Health (CAH) United States $17.396B 10.86
Cooper (COO) United States $17.371B 28.61
Straumann Holding AG (SAUHF) Switzerland $15.709B 0.00
West Pharmaceutical Services (WST) United States $12.917B 53.88
DENTSPLY SIRONA (XRAY) United States $12.867B 25.15
CONMED (CNMD) United States $2.976B 39.57
Merit Medical Systems (MMSI) United States $2.259B 26.39
Patterson (PDCO) United States $2.203B 16.32
STAAR Surgical (STAA) United States $1.644B 85.84
Atrion (ATRI) United States $1.268B 34.94
Antares Pharma (ATRS) United States $0.583B 357.00
Invacare (IVC) United States $0.302B 0.00
Lifevantage (LFVN) United States $0.226B 18.93
Pro-Dex (PDEX) United States $0.073B 20.14
Biolase (BIOL) United States $0.021B 0.00
Endologix (ELGX) United States $0.015B 0.00